Craving Management Program for Substance Use Disorders

Starting soon · Not applicable

Conditions studied: Substance Use Disorder (SUD)

In brief

This study examines whether a newly developed eight-session psychosocial treatment program, called the Craving Management and Alternative Behavior Enhancement Program, can be delivered in real-world hospital settings to people receiving inpatient care for substance use disorders in Korea, and whether it shows early signs of benefit. The program combines motivational interviewing, acceptance and commitment therapy, behavioral activation, and group activities, and is delivered twice a week over about four weeks (eight 50-minute sessions). About 20 adults will take part at two psychiatric hospitals. Participants complete brief questionnaires and a short interview about their craving, motivation to change, behavioral activation, positive and negative affect, mindfulness, and drug use history before the program, immediately before and after each session, within one week after the program ends, and again at 1 month and 3 months after completion. After the program, some participants also join a small group discussion (focus group interview) to share their experience of the program. Because this is a small, single-group preliminary (pilot) study without a comparison group, its primary purpose is to assess feasibility, that is, whether the program and the assessment approach work well enough, and to obtain preliminary effect and variability estimates to inform the design of a future large-scale randomized controlled trial.

Key facts

Study ID

NCT07698808

Run by

The Catholic University of Korea

People needed

20

Starts

2026-08-01

Expected to finish

2026-12-01

Last updated by the study team

2026-07-13

Who can join

Age: 19 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 19 to 65 years who can understand the study purpose and procedures and provide written informed consent
• Currently hospitalized (inpatient)
• Able to communicate and complete questionnaires in Korean
• Physically able to participate in program activities
• Has completed detoxification treatment
• Meets indication thresholds: DAST-10 score >= 2, craving reported as present on the VAS-C craving screening (i.e., "yes"), and >= 2 DSM-5 criteria

You may not qualify if…

• Cognitive impairment that precludes communication
• Physical conditions that preclude program participation (e.g., musculoskeletal disorder, severe cardiopulmonary disease)
• Acute psychotic symptoms or risk of self-harm or harm to others
• At risk of disrupting group activities such that focus group participation is not feasible
• Individuals who are inmates or incarcerated at screening are not enrolled; participants who become incarcerated after enrollment are withdrawn

Where it is running

• Daegu Daedong Hospital — Daegu, South Korea
• Incheon Chamsarang Hospital — Incheon, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.